Bone Therapeutics SA appointed Jean Stéphenne as the chairman of the company's board, effective Feb. 20.
Stéphenne replaces Steve Swinson, who informed the board of his intention to step down.
Previously, Stéphenne has served as a member of the corporate executive team at GlaxoSmithKline PLC and CEO of GSK Vaccines, formerly known as GSK Biologicals.
